Global Influenza Testing Market, By Test Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), Product (Point-Of-Care Testing, Immunodiagnostics, Molecular Diagnostics), Type-of-Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals/Clinical Laboratories, Reference Laboratories, Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Influenza Testing Market
Influenza testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 8.4% in the above-mentioned forecast period.
Influenza is basically a communicable flu that is caused by virus and spreads when people come in contact with the affected person. The influenza testing is generally done to check the main reason of the disease and proper diagnosis is being started to cure the patient. These testing procedure are used across the various end use industries such as the hospitals/clinical laboratories, reference laboratories and other end users.
Growing incidence of influenza diseases due to influenza virus and rising demand for rapid disease diagnosis are the significant factors responsible for driving the growth of the influenza testing market in the above-mentioned forecast period. Additionally, the increasing focus on quality of healthcare along with the growing concern of faster diagnosis and influenza control also heighten the overall growth of the market. On the other hand, the factors such as high cost included in influenza testing procedures obstruct the market’s growth in the forecast period of 2022 to 2029.
Furthermore, the growth in influenza research for diagnostic technologies are expected to generate profitable opportunities for the market in the forecast period of 2022 to 2029. On the other hand, the stringent regulatory framework have the potential to challenge for the market’s growth.
This influenza testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research influenza testing market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Influenza Testing Market Scope and Market Size
Influenza testing market is segmented on the basis of product, test type, type of flu and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, market is segmented into point-of-care testing, immunodiagnostics and molecular diagnostics.
- On the basis of the test type, the influenza testing market has been segmented into traditional diagnostic tests and molecular diagnostic tests. Traditional diagnostic tests are further segmented into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests and serological assays. Molecular diagnostic tests are further segmented into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAM), simple amplification-based assays (SAMBA) and other molecular diagnostic tests.
- On the basis of type of flu, the influenza testing market has been segmented into type A flu, type B flu and type C flu.
- The influenza testing market has also been segmented based on the end-user into hospitals/clinical laboratories, reference laboratories and other end users.
Influenza Testing Market Country Level Analysis
Influenza testing market is analyzed and market size insights and trends are provided by product, test type, type of flu and end user as referenced above.
The countries covered in the influenza testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the large market share of U.S. in the influenza testing market while due to the occurrence of influenza and advanced healthcare facilities in the forecast period of 2022 to 2029. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the increasing demand of the advanced diagnostic technologies in the region.
The country section of the influenza testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Influenza testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for influenza testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the influenza testing market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Influenza Testing Market Share Analysis
Influenza testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to influenza testing market.
Some of the major players operating in the influenza testing market report are Abbott, BD, CorisBioconcept, F. Hoffmann-La Roche Ltd, Luminex Corporation, Meridian Life Science, Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific, Analytik Jena GmbH, Bio-Rad Laboratories, Inc., Illumina, Inc., bioMérieux SA, Cepheid, GenMark Diagnostics, Inc., Danaher, SA Scientific Ltd., QIAGEN and BODITECH MED INC among others.
In March 2021, Luminex Corporation submitted an Emergency Use Authorization application to the US Food and Drug Administration for its new multi-analyte respiratory panel, which includes targets for influenza A/B, respiratory syncytial virus (RSV), and SARS-CoV-2.